BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8720143)

  • 1. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.
    Ishihara M; Takano R; Kanda T; Hayashi K; Hara S; Kikuchi H; Yoshida K
    J Biochem; 1995 Dec; 118(6):1255-60. PubMed ID: 8720143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2.
    Ishihara M; Kariya Y; Kikuchi H; Minamisawa T; Yoshida K
    J Biochem; 1997 Feb; 121(2):345-9. PubMed ID: 9089410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
    Ishihara M
    Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
    Guimond S; Maccarana M; Olwin BB; Lindahl U; Rapraeger AC
    J Biol Chem; 1993 Nov; 268(32):23906-14. PubMed ID: 7693696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
    J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of fibroblast growth factor 1 binding heparan sulfate domain.
    Kreuger J; Prydz K; Pettersson RF; Lindahl U; Salmivirta M
    Glycobiology; 1999 Jul; 9(7):723-9. PubMed ID: 10362842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins.
    Naggi A; De Cristofano B; Bisio A; Torri G; Casu B
    Carbohydr Res; 2001 Dec; 336(4):283-90. PubMed ID: 11728396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
    Ye S; Luo Y; Lu W; Jones RB; Linhardt RJ; Capila I; Toida T; Kan M; Pelletier H; McKeehan WL
    Biochemistry; 2001 Dec; 40(48):14429-39. PubMed ID: 11724555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor.
    Kariya Y; Kyogashima M; Suzuki K; Isomura T; Sakamoto T; Horie K; Ishihara M; Takano R; Kamei K; Hara S
    J Biol Chem; 2000 Aug; 275(34):25949-58. PubMed ID: 10837484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.
    Borgenström M; Jalkanen M; Salmivirta M
    J Biol Chem; 2003 Dec; 278(50):49882-9. PubMed ID: 14514688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features in heparin that interact with VEGF165 and modulate its biological activity.
    Ono K; Hattori H; Takeshita S; Kurita A; Ishihara M
    Glycobiology; 1999 Jul; 9(7):705-11. PubMed ID: 10362840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of disaccharides derived from heparin and evaluation of effects on endothelial cell growth and on binding of heparin to FGF-2.
    O'Brien A; Lynch C; O'Boyle KM; Murphy PV
    Carbohydr Res; 2004 Oct; 339(14):2343-54. PubMed ID: 15388349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
    Mansukhani A; Dell'Era P; Moscatelli D; Kornbluth S; Hanafusa H; Basilico C
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3305-9. PubMed ID: 1373495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.
    Atha DH; Lormeau JC; Petitou M; Rosenberg RD; Choay J
    Biochemistry; 1987 Oct; 26(20):6454-61. PubMed ID: 3427019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural observation of complexes of FGF-2 and regioselectively desulfated heparin in aqueous solutions.
    Yuguchi Y; Kominato R; Ban T; Urakawa H; Kajiwara K; Takano R; Kamei K; Hara S
    Int J Biol Macromol; 2005 Mar; 35(1-2):19-25. PubMed ID: 15769511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
    Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
    Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.